Disease/Condition
267 Clinical Trials
10+ Countries
Plaque Psoriasis Clinical Trials Database - Free Access to 267 Studies
Access comprehensive clinical trial information for Plaque Psoriasis through Pure Global AI's free database. This collection includes 267 clinical trials across multiple phases including Phase 3, N/A, Phase 2. Currently, 38 trials are actively recruiting participants.
Research for Plaque Psoriasis is being conducted in United States of America, China, Canada,United States of America and 7+ other countries. Leading sponsors include Novartis Pharmaceuticals and Therapeutics, Inc.. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
Phase 3
74N/A
62Phase 2
60Phase 4
38Phase 1
24By Status
Completed
161Recruiting
38Not yet recruit...
30Terminated
14Unknown
11Top Countries
United States of America79
China23
Canada,United States of America16
Germany11
Canada9
Top Sponsors
Novartis Pharmaceu...12
Therapeutics, Inc.11
Amgen11
Pfizer9
Eli Lilly and Comp...8
Recent Trials
Latest clinical trials for Plaque Psoriasis
2019-004141-32
A Randomized, Active-Controlled, Efficacy Assessor-Blinded Study to Evaluate Pharmacokinetics, Safety and Efficacy of Risankizumab in Patients from 6 to Less than 18 Years of Age with Moderate to Severe Plaque Psoriasis
AbbVie Deutschland GmbH & Co. ...
NCT06396013
Phase 1
Not yet recr...
A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome.
Beijing Hospital of Traditiona...
NCT06382987
Recruiting
A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)
Bristol-Myers SquibbJapan
NCT06370156
Not yet recr...
Evaluation of TWEAK in Plaque Psoriasis and Psoriatic Arthritis Patients
EgymedicalpediaEgypt
NCT06338358
Not yet recr...
Understanding Participation Habits Among Plaque Psoriasis Patients
Power Life Sciences Inc.United States of America
NCT06336343
Phase 4
Recruiting
Bimekizumab in Plaque Psoriasis
Icahn School of Medicine at Mo...United States of America
NCT06278350
Phase 2
Recruiting
Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis
InventisBio Co., LtdChina
NCT06220604
Phase 3
Recruiting
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)
Janssen Research & Development...Australia,South Korea,Taiwan
NCT06143878
Phase 3
Not yet recr...
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Janssen Research & Development...
NCT06122649
Phase 3
Recruiting
A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)
AmgenChina
NCT06108544
Phase 3
Recruiting
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period
TakedaUnited States of America
NCT06106230
Not yet recr...
Bee Venom Phonophoresis on Mild to Moderate Localized Plaque Psoriasis on Knee Joint
MTI UniversityEgypt
NCT06095102
Phase 3
Recruiting
A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)
Janssen Research & Development...Taiwan,United States of America
NCT06095115
Phase 3
Recruiting
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
Janssen Research & Development...United States of America
NCT06088199
Phase 3
Recruiting
A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
AmgenUnited States of America
NCT06088043
Phase 3
Recruiting
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment
TakedaUnited States of America
NCT06104644
Recruiting
A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany (DELPHIN)
Bristol-Myers SquibbGermany
NCT06058546
Phase 2
Not yet recr...
Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis
Tasly Pharmaceutical Group Co....China
NCT06030076
Not yet recr...
A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis
Almirall, S.A.
NCT06005532
Phase 3
Not yet recr...
Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®
Mabscale, LLCRussian Federation
About Plaque Psoriasis Research
Pure Global AI provides free access to 267 clinical trials studying Plaque Psoriasis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Novartis Pharmaceuticals, Therapeutics, Inc., Amgen, among others.
Quick Facts
Total Trials267
Countries10+
Sponsors10+
Recruiting38